| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chao Zhou CEO | HKEX Exchange | G210A7101 CUSIP |
| Hong Kong Country | 12,614 Employees | 12 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Grand Pharmaceutical Group Limited, originally known as China Grand Pharmaceutical and Healthcare Holdings Limited, operates as an investment holding entity dedicated to the pharmaceutical sector. Its business model encompasses the research and development, production, and distribution of a broad spectrum of pharmaceutical products and medical devices. The company is also involved in biotechnology and healthcare products, alongside the provision of pharmaceutical raw materials. With a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University for ophthalmic drug research and development, Grand Pharmaceutical Group Limited has positioned itself as a significant player in the pharmaceutical industry within and outside the People's Republic of China. Founded in 1995 and headquartered in Central, Hong Kong, the company has expanded its operational reach to include Asia, the United States, Europe, and other global markets.